IntegraGen Announces €2 Million Equity Investment By DSM Venturing, Alongside R&D Partnership With DSM Personalized Nutrition Group

PARIS--(BUSINESS WIRE)--IntegraGen, the personalized healthcare company focused on the development and commercialization of genetic tests for complex diseases, has announced that DSM Venturing, the corporate venturing arm of Royal DSM N.V. has invested €2M in the Company. In addition, it has entered into a collaborative R&D partnership with the DSM Personalized Nutrition Group for the development of molecular diagnostic products for personalized healthcare.